Analysis of Binding Interaction Between Antibacterial Ciprofloxacin and Human Serum Albumin by Spectroscopic Techniques

Cell Biochemistry and Biophysics

Volumn 70, Issue 1, 2014, Pages 93-101

  Varshney, Ankita ^a   Ansari, Yunus ^a   Zaidi, Nida ^a   Ahmad, Ejaz ^a   Badr, Gamal ^b   Alam, Parvez ^a   Khan, Rizwan Hasan ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b Assiut University   (Egypt)

Author keywords

Binding parameters; Ciprofloxacin (CFX); Circular dichroism; Human serum albumin

Indexed keywords

ANTIINFECTIVE AGENT; BILIRUBIN; CHLOROFORM; CIPROFLOXACIN; DIAZEPAM; HEMIN; PROTEIN BINDING; SERUM ALBUMIN;

BINDING SITE; CHEMISTRY; DRUG EFFECTS; HUMAN; METABOLISM; PH; PROTEIN SECONDARY STRUCTURE; SPECTROSCOPY;

ANTI-BACTERIAL AGENTS; BILIRUBIN; BINDING SITES; CHLOROFORM; CIPROFLOXACIN; DIAZEPAM; HEMIN; HUMANS; HYDROGEN-ION CONCENTRATION; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SERUM ALBUMIN; SPECTRUM ANALYSIS;

EID: 84906222280     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-9863-1     Document Type: Article

References (28)

1. Bhattacharya, A. A., Grüne, T., & Curry, S. (2000). Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. Journal of Molecular Biology, 303, 721-732.
2. Varshney, A., Sen, P., Ahmed, E., Rehan, M., & Subbarao, N. (2010). Ligand binding strategies of human serum albumin: how can the cargo be utilized. Chirality, 22, 77-87.
3. Gulam, J., Zunszain, P. A., Petipas, I., Bhattacharaya, A. A., Otagiri, M., & Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353, 38-52.
4. Zaidi, N., Ahmad, E., Rehan, M., Rabbani, G., Ajmal, M. R., Zaidi, Y., et al. (2013). Biophysical insight into furosemide binding to human serum albumin: a study to unveil its impaired albumin binding in uremia. Journal of Physical Chemistry B, 117, 2595-2604.
5. Zaidi, N., Ajmal, M. R., Rabbani, G., Ahmad, E., & Khan, R. H. (2013). A comprehensive insight into binding of hippuric acid to human serum albumin: a study to uncover its impaired elimination through hemodialysis. PLoS One, 8, e71422.
6. Peters, T. (1996). All about albumin. Biochemistry, genetics and medical applications. San Diego: Academic Press.
7. Gabor, M., & Fred, K. (1957). The disulfide bonds of human serum albumin and bovine γ-globulin. Journal of American Chemical Society, 79, 134-139.
8. Sugio, S., Kashima, A., Mockizuki, S., Noda, M., & Kobayashi, K. (1999). Crystal structure of human serum albumin at 2. 5 Å resolution. Protein Engineering, 12, 439-446.
9. Vorobey, P., Steindal, A. E., Vorobey, A., & Moan, J. (2006). Influence of human serum albumin on photodegradation of folic acid in solution. Journal of Photochemistry Photobiology, 82, 817-822.
10. Bhagvan, N. V., & Ha, C. E. (2013). Novel insight into the pleiotropic effects of human serum albumin in health and disease. Biochemica et Biophysica Acta General subjects, 12, 5486-5493.
11. Lode, H. (1999). Potential interactions of the extended spectrum fluoroquinolones with the CNS. Drug Safety, 2, 123-135.
12. Benet, L. Z., & Hoener, B. A. (2002). Changes in plasma protein binding have little clinical relevance. Clinical Pharmacology Therapeutics, 71, 115-121.
13. Herve, F., Urien, S., Albengres, E., Duche, J. C., & Tillement, J. P. (1994). Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding. Clinical Pharmacokinetics, 26, 44-58.
14. Levine, R. R. (2000). Pharmacology: Drug actions and reactions (6th ed.). New York: The Parthenon Publishing Group.
15. Pratt, W. B., & Taylor, P. (1990). Principles of drug action: The basis of pharmacology (3rd ed.). New York: Churchill Livingstone Inc.
16. Khan, M. Y. (1986). Direct evidence for the involvement of domain III in the N-F transition of bovine serum albumin. Biochemical Journal, 236, 307-310.
17. Curry, S., Mandelkow, H., Brick, P., & Franks, N. (1998). Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nature Structural Biology, 5, 827-835.
18. He, X. M., & Carter, D. C. (1992). Atomic structure and chemistry of human serum albumin. Nature, 358, 209-215.
19. Wallevik, K. (1973). Reversible denaturation of human serum albumin by pH, temperature, and guanidine hydrochloride followed by optical rotation. Journal of Biological Chemistry, 248, 2650-2655.
20. Lowry, O. H., Rosebrough, N. J., Farr, A. L., & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
21. Zunszain, P. A., Ghuman, J., Komatsu, T., Tsuchida, E., & Curry, S. (2003). Crystal structural analysis of human serum albumin complexed with hemin and fatty acid. BMC Structural Biology, 3, 1-9.
22. Kratochwil, N. A., Huber, W., Muller, F., Kansy, M., & Gerber, P. R. (2002). Predicting plasma protein binding of drugs: a new approach. Biochemical Pharmacology, 64, 1355-1374.
23. Kang, J., Liu, Y., Xie, M. X., Li, S., Jiang, M., & Wang, Y. D. (2004). Interactions of human serum albumin with chlorogenic acid and ferulic acid. Biochimica Biophysica Acta, 1674, 205-214.
24. Johansson, J. S. (1997). Binding of the volatile anesthetic chloroform to albumin demonstrated using tryptophan fluorescence quenching. Journal of Biological Chemistry, 272, 17961-17965.
25. Kragh-Hansen, U. (1988). Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands. Molecular Pharmacology, 34, 160-171.
26. Silva, D., Cortez, C. M., Cunha-Bastos, J., & Louro, S. R. W. (2004). Methyl parathion interaction with human and bovine serum albumin. Toxicology Letters, 147, 53-61.
27. Kelly, S. M., & Price, N. N. (2000). The use of circular dichroism in the investigation of protein structure and function. Current Protein and Peptide Science, 1, 349-384.
28. Ahmad, B., Parveen, S., & Khan, R. H. (2006). Effect of albumin conformation on the binding of ciprofloxacin to human serum albumin: a novel approach directly assigning binding site. Biomacromolecules, 7, 1350-1356.